Yan Katsnelson

Dr. Yan Katsnelson is an entrepreneur, highly skilled cardiac surgeon, business owner, and philanthropist. He is the founder and CEO of USA Vein Clinics, which is part of USA Clinics Group – the parent company of USA Fibroid Centers, USA Vascular Centers, USA Hemorrhoid Centers, USA Prostate Centers, and USA Oncology Centers. Dr. Katsnelson has established himself as a strong advocate for accessible, affordable, and compassionate healthcare services.

As the CEO of USA Clinics Group, Dr. Katsnelson has pioneered expanding minimally invasive options that provide high-quality care using the latest technology in the most advanced facilities to the communities that need it most. He also founded the Chicago Heart Institute, which was dedicated to the advanced treatments of cardiovascular diseases.

Dr. Katsnelson completed a fellowship at the Brigham and Women’s Hospital, Harvard School of Medicine, in Boston, MA. He was a faculty cardiac surgeon at the University of Chicago prior to starting his Cardiovascular and Thoracic private practice in Chicago Northwest suburbs. Dr. Katsnelson was the first U.S. surgeon to perform the double valve replacement using Biocor™ tissue valve. His clinical areas of expertise included minimally invasive valve surgery, complex aortic operations, re-operative coronary and valve surgery, and beating-heart (off-pump) bypass surgery. He is published in various medical and scientific journals.

His vision of healthcare combines advanced medical and informational technology and creates a unique, data-driven approach that enables individualized treatment planning and achieves consistent outcomes. He developed a comprehensive healthcare management platform to optimize each patient’s experience before, during and after an appointment with streamlined scheduling, insurance verification, prior authorizations, clinical decision-management support, and treatment process quality assurance.

Dr. Katsnelson also started the Fibroids Fighters Foundation to advance the cause of women’s health and the safe and effective minimally invasive treatment of uterine fibroids. He is member of the international Save a Child’s Heart that provides life-saving cardiac treatment to children from underdeveloped countries. Dr Katsnelson leads development of ECHO assisted technology that enables screening of thousands of children worldwide.